INVO Fertility, Inc. $IVF

By Microcap Ledger desk · CIK 0001417926

Facts as of Oct 11, 2026, 08:19 AM UTC. Built from SEC filings and our own data. Small caps move fast; check the latest filings.

Snapshot

Exchange: Nasdaq Capital Market
Sector: Surgical & Medical Instruments & Apparatus
Headquarters: Sarasota, FL
Fiscal year end: December 31
Shares outstanding: 2,506,969 [10-Q 2026-08-14]
as of 2026-08-14

Sources: [10-K 2026-06-02]

What the company doesAI summary of filing

INVO Fertility, Inc. is a healthcare services and technology company focused on the fertility marketplace. The company operates fertility clinics that provide assisted reproductive technology services including in vitro fertilization (IVF) and intravaginal culture (IVC) procedures enabled by its INVOcell medical device, and also sells and distributes the INVOcell device to third-party fertility clinics. As of the filing date, the company operates four fertility clinics in the United States and generates revenue from both clinic operations and device sales. The company is revenue-generating, with the Wisconsin Fertility Institute acquisition in August 2023 significantly expanding its clinic-based operations and cash flow. [10-K 2026-06-02]

Segments: Fertility Clinics, INVOcell Device

Financial health

From XBRL company facts (USD)
Period	Revenue	Net income	Operating cash flow	Cash	Filing
6 months to Jun 2026	$4.19M	−$4.65M	−$3.02M	$3.73M	[10-Q 2026-08-14]
FY ended Dec 2025	$6.84M	$23.32M	−$7.01M	$2.08M	[10-K 2026-06-02]
FY ended Dec 2024	$6.53M	$9.05M	−$2.97M	$619.5K	[10-K 2026-06-02]

Quarterly cash burn: −$1.51M
Cash runway Estimate: ~7.4 months

Capital structure and dilution

Summary only. How these instruments work: Dilution & financing desk.

Share count
Date	Shares outstanding	Filing
2025-04-29	1,066,065	[10-K 2025-04-30]
2025-05-20	2,149,131	[10-Q 2025-05-20]
2025-08-14	4,363,016	[10-Q 2025-08-14]
2025-11-17	15,130,282	[10-Q 2025-11-17]
2026-06-02	1,786,035	[10-K 2026-06-02]
2026-06-12	1,786,035	[10-K/A 2026-06-12]
2026-06-22	1,786,035	[10-Q 2026-06-22]
2026-08-14	2,506,969	[10-Q 2026-08-14]

Shelf registration: S-1 filed 2026-07-24; declared effective 2026-08-04 [S-1 2026-07-24]

Listing status

Current status: 4 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-04-29. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.

Date	Event	Details	Deadline	Filing
2026-04-29	8-K Item 3.01	Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing	—	[8-K 2026-04-29]
2025-04-18	8-K Item 3.01	Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing	—	[8-K 2025-04-18]
2025-03-31	8-K Item 3.01	Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing	—	[8-K 2025-03-31]
2025-01-16	8-K Item 3.01	Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing	—	[8-K 2025-01-16]

More on deficiency notices and uplistings: Listing status desk.

Who owns it

Recent Form 4 transactions
Date	Insider	Type	Shares	Price	Filing
2025-12-04	Szot Matthew K	other	3	—	[4 2025-12-05]
2025-12-03	Szot Matthew K	sell	4	$1.52	[4 2025-12-05]

Catalysts and calendar

Recent filings and releases
Date	Type	Title
2026-10-09	13G/A	Beneficial ownership report (5%+ holder)
2026-08-28	8-K	Regulation FD disclosure; Other events
2026-08-17	8-K	Results of operations
2026-08-14	10-Q	Quarterly report
2026-08-14	13G/A	Beneficial ownership report (5%+ holder)
2026-08-07	13G	Beneficial ownership report (5%+ holder)
2026-08-07	424B3	Prospectus or prospectus supplement
2026-07-24	S-1	Registration statement
2026-07-24	8-K	Material agreement entered; Unregistered sale of equity; Charter, bylaws or fiscal year change
2026-06-25	8-K	Material agreement entered; Other events
2026-06-23	DEF 14A	Proxy statement
2026-06-22	8-K	Results of operations

Facts as of Oct 11, 2026, 08:19 AM UTC. Small caps move fast; check the latest filings.